查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1607987

皰疹標記測試市場：按適應症、測試類型和應用分類 - 2025-2030 年全球預測

Herpes Marker Testing Market by Indication (HSV-1, HSV-2), Test Type (Antibody or Antigen-based Kits, Nucleic Acid Amplification based Kits, Viral Culture Test), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，皰疹標記檢測市場價值為4.6822億美元，預計到2024年將達到4.9786億美元，複合年成長率為6.46%，到2030年將達到7.2583億美元。

單純皰疹病毒 (HSV) 感染透過檢測生物樣本中的病毒抗原和抗體的臨床檢測來識別和管理。全球 HSV感染疾病的高盛行率、及時準確的診斷以進行有效的疾病管理以及對個人化醫療的需求不斷成長，推動了對皰疹標記物檢測的需求。應用範圍從醫療機構的常規診斷業務到旨在了解病毒流行病學和開發疫苗的研究和開發。最終用戶主要是醫院、診斷實驗室和研究機構。市場成長受到分子檢測技術進步、性行為感染感染（STI）意識提高以及醫療保健支出增加等因素的影響。然而，成長面臨的挑戰包括先進診斷系統的高成本、資源匱乏地區的有限就地檢驗以及與性傳染感染相關的社會恥辱，這些都阻礙了人們得到診斷。新的商機在於在醫療保健基礎設施正在開發的發展中地區擴大檢測服務，以及旨在提高檢測準確性和縮短獲得結果的時間的持續研發工作。企業可以利用家庭檢測套組和數位健康平台的不斷成長趨勢進行遠距離診斷。然而，監管監督以及對測試結果的高特異性和敏感性的需求仍然是重要的障礙。該領域的創新可集中於開發適合家庭使用的經濟高效、快速出結果的檢測套組，以及整合人工智慧以進行預測診斷和個人化治療計劃。市場競爭處於中度和高度活躍狀態，永續成長需要策略夥伴關係和持續創新。整體而言，有針對性的研發投資和策略性市場擴大策略將是利用未來成長機會同時克服現有挑戰的關鍵。

主要市場統計
基準年[2023] 46822萬美元
預計年份 [2024] 4.9786 億美元
預測年份 [2030] 72583萬美元
複合年成長率（%） 6.46%

市場動態：揭示快速發展的皰疹標記測試市場的關鍵市場洞察

供需的動態交互作用正在改變皰疹標記物檢測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 人群中皰疹感染的盛行率
    • 提高對口腔和生殖器感染的早期診斷和治療的認知
    • 增加醫療支出並改善醫療基礎設施
  • 市場限制因素
    • 由於缺乏技術人員而缺乏測試實驗室
  • 市場機會
    • 介紹新開發的皰疹檢測套組
    • 增加治療皰疹感染疾病的新疫苗的研究活動
  • 市場挑戰
    • 核准過程艱難且漫長

波特的五力：駕馭皰疹標記物測試市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解外部對皰疹標記檢測市場的影響

外部宏觀環境因素在塑造皰疹標記測試市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解皰疹標記物檢測市場的競爭狀況

對皰疹標記物測試市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣皰疹標記檢測市場供應商績效評估

FPNV定位矩陣是評估皰疹標記物檢測市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了皰疹標誌物測試市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，皰疹標記測試市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人群中皰疹感染的盛行率
      • 提高對口腔和生殖器感染疾病的早期診斷和治療的認知
      • 醫療成本上升和醫療基礎設施改善
    • 抑制因素
      • 實驗室數量有限，缺乏熟練的人力資源。
    • 機會
      • 介紹新開發的皰疹檢測套組
      • 治療皰疹感染疾病的新疫苗的研究活動活性化
    • 任務
      • 嚴格而漫長的核准流程
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 皰疹標記測試市場（按適應症）

  • HSV-1
  • HSV-2

第7章按測試類型分類的皰疹標記測試市場

  • 基於抗體或抗原的套件
  • 基於核酸擴增的套件
  • 病毒培養測試

第8章皰疹標記測試市場：按應用分類

  • 臨床
  • 調查

第9章 北美和南美皰疹標記檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區皰疹標記檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲皰疹標記檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Abcam PLC
  • AdvaCare Pharma
  • Bio-Diagnostics Ltd.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Biopanda Reagents Ltd.
  • CTK Biotech, Inc.
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd.
  • Genome Diagnostics Pvt. Ltd.
  • Hologic, Inc.
  • InTec PRODUCTS, INC.
  • Merck KGaA
  • Meridian Bioscience, Inc. by SD Biosensor, Inc.
  • Norgen Biotek Corporation
  • QED Bioscience, Inc.
  • Qiagen NV
  • Quidel Corporation
  • Rapid STD Testing by RSC Health, PA
  • Teco Diagnostics
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-DD0700E81D12

The Herpes Marker Testing Market was valued at USD 468.22 million in 2023, expected to reach USD 497.86 million in 2024, and is projected to grow at a CAGR of 6.46%, to USD 725.83 million by 2030.

Herpes marker testing is a crucial segment within the broader diagnostic testing market, focused on identifying and managing herpes simplex virus (HSV) infections through clinical assays that detect viral antigens or antibodies in biological samples. The necessity for herpes marker testing is driven by the high prevalence of HSV infections globally, the need for timely and accurate diagnosis for effective disease management, and the rising demand for personalized medicine. Applications range from routine diagnostic practices in healthcare facilities to research explorations aimed at understanding the virus's epidemiology and developing vaccines. End-users primarily include hospitals, diagnostic laboratories, and research institutions. Market growth is influenced by factors like advancements in molecular testing technologies, increasing awareness about sexually transmitted infections (STIs), and rising healthcare expenditure. However, challenges to growth include the high costs of advanced diagnostic systems, limited availability of point-of-care testing in low-resource regions, and social stigma associated with STIs hindering individuals from seeking diagnosis. Emerging opportunities lie in the expansion of testing services in developing regions with improving healthcare infrastructure and the ongoing R&D efforts to enhance test precision and reduce time-to-result. Companies can capitalize on the growing trend towards home-based testing kits and digital health platforms for remote diagnosis. However, regulatory scrutiny and the need for high specificity and sensitivity in test results remain critical barriers. Innovation in this space could focus on developing cost-effective, rapid-result test kits suitable for home use and integrating artificial intelligence for predictive diagnosis and personalized treatment plans. The market is dynamic with moderate to high competition, requiring strategic partnerships and continuous innovation for sustained growth. Overall, targeted investment in R&D, coupled with strategic market expansion strategies, will be key to capitalizing on future growth opportunities while navigating existing challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 468.22 million
Estimated Year [2024] USD 497.86 million
Forecast Year [2030] USD 725.83 million
CAGR (%) 6.46%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Herpes Marker Testing Market

The Herpes Marker Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of herpes infections among population
    • Growing awareness of early diagnosis and treatments of oral and genital infection
    • Rising healthcare spendings and improved healthcare infrastructure
  • Market Restraints
    • Limited availability of laboratories along with lack of skilled personnel
  • Market Opportunities
    • Introduction of newly developed herpes testing kits
    • Growing research activities for novel vaccines to treat herpes infections
  • Market Challenges
    • Stringent and time consuming approval processes

Porter's Five Forces: A Strategic Tool for Navigating the Herpes Marker Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Herpes Marker Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Herpes Marker Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Herpes Marker Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Herpes Marker Testing Market

A detailed market share analysis in the Herpes Marker Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Herpes Marker Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Herpes Marker Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Herpes Marker Testing Market

A strategic analysis of the Herpes Marker Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Herpes Marker Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, AdvaCare Pharma, Bio-Diagnostics Ltd., Bio-Rad Laboratories, Inc., bioMerieux SA, Biopanda Reagents Ltd., CTK Biotech, Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Genome Diagnostics Pvt. Ltd., Hologic, Inc., InTec PRODUCTS, INC., Merck KGaA, Meridian Bioscience, Inc. by SD Biosensor, Inc., Norgen Biotek Corporation, QED Bioscience, Inc., Qiagen N.V., Quidel Corporation, Rapid STD Testing by RSC Health, PA, Teco Diagnostics, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Herpes Marker Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across HSV-1 and HSV-2.
  • Based on Test Type, market is studied across Antibody or Antigen-based Kits, Nucleic Acid Amplification based Kits, and Viral Culture Test.
  • Based on Application, market is studied across Clinical and Research.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of herpes infections among population
      • 5.1.1.2. Growing awareness of early diagnosis and treatments of oral and genital infection
      • 5.1.1.3. Rising healthcare spendings and improved healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of laboratories along with lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of newly developed herpes testing kits
      • 5.1.3.2. Growing research activities for novel vaccines to treat herpes infections
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent and time consuming approval processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Herpes Marker Testing Market, by Indication

  • 6.1. Introduction
  • 6.2. HSV-1
  • 6.3. HSV-2

7. Herpes Marker Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Antibody or Antigen-based Kits
  • 7.3. Nucleic Acid Amplification based Kits
  • 7.4. Viral Culture Test

8. Herpes Marker Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical
  • 8.3. Research

9. Americas Herpes Marker Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Herpes Marker Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Herpes Marker Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Abcam PLC
  • 3. AdvaCare Pharma
  • 4. Bio-Diagnostics Ltd.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. bioMerieux SA
  • 7. Biopanda Reagents Ltd.
  • 8. CTK Biotech, Inc.
  • 9. DiaSorin S.p.A.
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Genome Diagnostics Pvt. Ltd.
  • 12. Hologic, Inc.
  • 13. InTec PRODUCTS, INC.
  • 14. Merck KGaA
  • 15. Meridian Bioscience, Inc. by SD Biosensor, Inc.
  • 16. Norgen Biotek Corporation
  • 17. QED Bioscience, Inc.
  • 18. Qiagen N.V.
  • 19. Quidel Corporation
  • 20. Rapid STD Testing by RSC Health, PA
  • 21. Teco Diagnostics
  • 22. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. HERPES MARKER TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. HERPES MARKER TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HERPES MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HERPES MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HERPES MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HERPES MARKER TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HERPES MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HERPES MARKER TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HSV-1, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HSV-2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY ANTIBODY OR ANTIGEN-BASED KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION BASED KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY VIRAL CULTURE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. HERPES MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. HERPES MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023